<DOC>
	<DOCNO>NCT01014182</DOCNO>
	<brief_summary>Several recent trial ( 1,2 ) suggest STEMI patient receive fibrinolysis non-PCI centre routinely transfer elective early PCI within 24 hour hospitalization , additive risk major bleed complication severe adverse event compare standard therapy . These result favour routine invasive strategy STEMI patient suggest potential change current approach await response treatment patient receive fibrinolysis , draw attention potential need appropriate network organization adequate first hospitalization treatment ( spoke ) prompt transfer centre 24/7 PCI capability ( hub ) . The recent ESC ( 3 ) ACC ( 4 ) guideline STEMI consistent early ESC PCI Guidelines , recommend angioplasty fibrinolysis perform within time-window range 3 24 hour successful lytic administration ( level evidence IIA ) . The reason weight recommendation due heterogeneity trial result different planned-revascularization strategy , variable primary end-points definition , small individual trial sample size . Therefore , consistent analysis single patient dataset publish randomized trial would value well define magnitude duration clinical benefit routine invasive strategy lytic treatment well potential optimal timing strategy . The main aim OTTER meta-analysis define benefit immediate PCI fibrinolysis STEMI patient . Moreover , OTTER meta-analysis investigate optimal time post-fibrinolysis elective revascularization .</brief_summary>
	<brief_title>Early Percutaneous Coronary Intervention ( PCI ) After Fibrinolysis Versus Standard Therapy ST Segment Elevation Myocardial Infarction ( STEMI ) Patients</brief_title>
	<detailed_description>All publish randomize control trial compare routine invasive strategy early PCI standard therapy STEMI patient fibrinolysis include analysis . We exclude non-randomized trial , randomize study individual patient data available analysis , randomize study angioplasty mainly perform without stenting ( &lt; 80 % stenting population ) type lytic therapy different modern fibrin-specific agent . Two investigator independently evaluate study possible inclusion . The quality search trial evaluate base 5-point scale outline Jadad et al ( 5 ) , criteria randomization proper concealment allocation sequence , blind patient investigator treatment allocation description blind method , completeness follow-up . Recruitment : An electronic database compile consist data single patient enrol trial , accord guideline performance individual patient meta-analysis. ( 6-7-8 ) . The database include demographic data baseline characteristic . Attention pay clinical complication transfer early PCI precise calculation follow times-window : symptom onset lytic therapy , lytic therapy early rescue PCI , randomization adverse event define . Data check completeness consistency publish report . Two investigator independently extract data , disagreement resolve consultation third investigator . End-points The following end-points investigate : Primary End Point : Combined death/reinfarction 30 day . Secondary end-points : - Death , reinfarction , recurrent ischemia urgent revascularization 30 day . - Combined death/reinfarction/recurrent ischemia/urgent revascularization new presentation CHF shock 30 day . - Major bleed hemorrhagic stroke 30 day . - Combined death/reinfarction combine revascularization/recurrent ischemia 6-12 month . Secondary analysis also investigate influence time post-thrombolysis early revascularization consider event . Investigators : The study coordinate Prof. C. Di Mario . An executive committee compose Principle Investigators enrol trial overview quality data collect ( OTTER Investigators ) . No publication send without write consent PIs individual trial . Statistical analysis perform Royal Brompton Hospital ( London ) Canadian Heart Research Centre ( Toronto , Ontario , Canada ) . References : 1 . Cantor WJ , Fitchett D , Borgundvaag B , Ducas J , et al . TRANSFER-AMI Trial Investigators . Routine early angioplasty fibrinolysis acute myocardial infarction . N Engl J Med . 2009 Jun 25 ; 360 ( 26 ) :2705-18 . 2 . Di Mario C , Dudek D , Piscione F , et al . Immediate angioplasty versus standard therapy rescue angioplasty thrombolysis Combined Abciximab REteplase Stent Study Acute Myocardial Infarction ( CARESS-in-AMI ) : open , prospective , randomize , multicentre trial . Lancet 2008 ; 371:559-568 . 3 . Van de Werf F , Bax J , Betriu A , et al . Management acute myocardial infarction patient present persistent ST-segment elevation : Task Force Management ST-Segment Elevation Acute Myocardial Infarction European Society Cardiology . Eur Heart J 2008 ; 29:2909-2945 . 4 . Antman EM , Hand M , Armstrong PW , et al . 2007 focused update ACC/AHA 2004 guideline management patient ST-elevation myocardial infarction : report American College Cardiology/American Heart Association Task Force Practice Guidelines . J Am Coll Cardiol 2008 ; 51:210-247 . 5 . Jadad AR , Moore RA , Carroll D , et al . Assessing quality report randomize clinical trial : blind necessary ? Control Clin Trials . 1996 Feb ; 17 ( 1 ) :1-12 . 6 . Simmonds MC , Higgins JP , Stewart LA , et al . Meta-analysis individual patient data randomize trial : review method use practice . Clin Trials . 2005 ; 2 ( 3 ) :209-17 . 7 . Clarke MJ , Stewart LA . Meta-analyses use individual patient data . J Eval Clin Pract . 1997 Aug ; 3 ( 3 ) :207-12. Review . PubMed PMID : 9406108 8 . Stewart LA , Clarke MJ . Practical methodology meta-analyses ( overview ) use update individual patient data . Cochrane Working Group . Stat Med . 1995 Oct 15 ; 14 ( 19 ) :2057-79 .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>STEMI patient enrol within 12 hour onset symptom Controlled randomized trial compare routine invasive strategy standard therapy STEMI patient Modern fibrinspecific therapy group Stenting PCI &gt; 80 % invasive procedure English language Cardiogenic shock presentation Need concomitant Major surgery Severe chronic renal hepatic impairment Myocardial infarction within previous 2 week Contraindications thrombolytic therapy , abciximab , aspirin , clopidogrel Non randomize trial Single patient data available Non fibrinspecific lytic therapy Stenting PCI &lt; 80 % invasive procedure Not English language</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Early PCI</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Thrombolysis</keyword>
	<keyword>Optimal revascularization therapy STEMI patient</keyword>
</DOC>